批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/06/15 |
SUPPL-53(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/08/14 |
SUPPL-48(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2015/01/26 |
SUPPL-47(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2014/03/20 |
SUPPL-46(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/08/13 |
SUPPL-41(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2012/12/11 |
SUPPL-43(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2007/11/06 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/08/18 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2003/05/28 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2003/02/25 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2003/01/27 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2003/01/27 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/02/16 |
SUPPL-18(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/01/26 |
SUPPL-17(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/02/23 |
SUPPL-15(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/01/19 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1995/10/04 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1994/01/13 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/11/24 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/07/01 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1992/12/18 |
SUPPL-8(补充) |
Approval |
Efficacy |
|
|
|
1992/12/18 |
SUPPL-3(补充) |
Approval |
Efficacy |
|
|
|
1991/10/21 |
SUPPL-9(补充) |
Approval |
Labeling |
|
|
|
1989/05/26 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1989/05/11 |
SUPPL-7(补充) |
Approval |
Labeling |
|
|
|
1988/08/15 |
SUPPL-6(补充) |
Approval |
Labeling |
|
|
|
1988/08/15 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1988/08/15 |
SUPPL-2(补充) |
Approval |
Labeling |
|
|
|
1988/08/15 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1986/12/31 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:ESMOLOL HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:1GM/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019386 |
004 |
NDA |
BREVIBLOC IN PLASTIC CONTAINER |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
1GM/100ML |
Prescription |
Yes |
Yes |
AP |
2001/02/16
|
BAXTER HLTHCARE |
206608 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
1GM/100ML |
Prescription |
No |
No |
AP |
2018/06/08
|
MYLAN LABS LTD |
207107 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
1GM/100ML |
Prescription |
No |
No |
AP |
2018/06/08
|
SAGENT PHARMS INC |
216244 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
1GM/100ML |
Prescription |
No |
No |
AP |
2022/03/21
|
EUGIA PHARMA |
214172 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
1GM/100ML |
Prescription |
No |
No |
AP |
2022/12/02
|
HQ SPCLT PHARMA |
216603 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
1GM/100ML |
Prescription |
No |
No |
AP |
2022/12/13
|
AMNEAL |
活性成分:ESMOLOL HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:2GM/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019386 |
005 |
NDA |
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
2GM/100ML |
Prescription |
Yes |
Yes |
AP |
2003/01/27
|
BAXTER HLTHCARE |
206608 |
002 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
2GM/100ML |
Prescription |
No |
No |
AP |
2018/06/08
|
MYLAN LABS LTD |
207107 |
002 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
2GM/100ML |
Prescription |
No |
No |
AP |
2018/06/08
|
SAGENT PHARMS INC |
216244 |
002 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
2GM/100ML |
Prescription |
No |
No |
AP |
2022/03/21
|
EUGIA PHARMA |
214172 |
002 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
2GM/100ML |
Prescription |
No |
No |
AP |
2022/12/02
|
HQ SPCLT PHARMA |
216603 |
002 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
2GM/100ML |
Prescription |
No |
No |
AP |
2022/12/13
|
AMNEAL |
活性成分:ESMOLOL HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:10MG/ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
019386 |
006 |
NDA |
BREVIBLOC |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
10MG/ML |
Prescription |
Yes |
Yes |
AP |
2003/02/25
|
BAXTER HLTHCARE |
076323 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
10MG/ML |
Prescription |
No |
No |
AP |
2004/08/10
|
HIKMA |
076474 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
10MG/ML |
Prescription |
No |
No |
AP |
2005/05/02
|
MYLAN INSTITUTIONAL |
076573 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
10MG/ML |
Discontinued |
No |
No |
AP |
2005/05/02
|
FRESENIUS KABI USA |
205520 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
10MG/ML |
Prescription |
No |
No |
AP |
2015/07/23
|
EUGIA PHARMA |
208538 |
001 |
ANDA |
ESMOLOL HYDROCHLORIDE |
ESMOLOL HYDROCHLORIDE |
INJECTABLE;INJECTION |
10MG/ML |
Prescription |
No |
No |
AP |
2019/08/14
|
GLAND PHARMA LTD |